Hims & Hers Drives the Consumer-Centric Transformation in Digital Care
HIMS leverages its consumer-first telehealth model, AI-driven personalization and global expansion plans to outpace industry growth.
Deal Dispatch: Performance Food Rejects Offer, Claire's Bankrupt - American Woodmark ( NASDAQ:AMWD ) , Boeing ( NYSE:BA )
Performance Food rejects offer; Bachan's, Hg and Yomeishu explore sales; Lufthansa drops Air Europa bid; NFL sells media to ESPN Skydance Media finally completed its $8-billion acquisition of Paramount Global. Sen. Warren called it a "wink, wink" arrangement.
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings - Doximity ( NYSE:DOCS )
Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of 36 cents per share which beat the analyst consensus estimate of 30 cents per share.
SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday - Blue Gold ( NASDAQ:BGL ) , Astrana Health ( NASDAQ:ASTH )
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Friday. Shares of SoundHound AI, Inc. SOUN rose sharply during Friday's session after the company reported better-than-expected second-quarter financial results and raised its FY25 sales guidance above estimates.
Pinterest To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday - Crocs ( NASDAQ:CROX ) , Doximity ( NYSE:DOCS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keefe, Bruyette & Woods raised Block Inc XYZ price target from $80 to $95.
Doximity ( DOCS ) Q1 Revenue Rises 15%
Doximity ( NYSE:DOCS ) , a leading digital platform for medical professionals, released results for Q1 FY2026 on August 7, 2025. The company posted GAAP revenue of $145.9 million, missing analyst expectations of $154.4 million ( GAAP ) by about 5.5%.
Doximity ( DOCS ) Q1 Earnings and Revenues Top Estimates
Doximity (DOCS) delivered earnings and revenue surprises of +16.13% and +4.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
Pathway's AI-powered clinical reference tool helps doctors answer questions about guidelines, drugs and trials.
Doximity Unusual Options Activity For August 07 - Doximity ( NYSE:DOCS )
Financial giants have made a conspicuous bullish move on Doximity. Our analysis of options history for Doximity DOCS revealed 11 unusual trades. Delving into the details, we found 63% of traders were bullish, while 27% showed bearish tendencies.
Is Doximity Gaining or Losing Market Support? - Doximity ( NYSE:DOCS )
Doximity's DOCS short percent of float has fallen 13.66% since its last report. The company recently reported that it has 4.97 million shares sold short, which is 3.73% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.02 days to cover ...
Claritev Corporation ( CTEV ) Q2 Earnings and Revenues Surpass Estimates
Claritev Corporation (CTEV) delivered earnings and revenue surprises of +111.90% and +4.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Health, Inc. ( HIMS ) Misses Q2 Earnings and Revenue Estimates
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -5.56% and -1.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
These top telehealth stocks look like smart growth plays right now.
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
HIMS is transforming digital healthcare with AI-driven care, a booming subscriber base, and new tech leadership.
Doximity ( DOCS ) Reports Next Week: Wall Street Expects Earnings Growth
Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
OPRX's subscription shift, DAAP platform, and HCP-DTC reach suggest a moat is forming-but is it built to last?
OMCL vs. DOCS: Which Stock Is the Better Value Option?
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell ( OMCL Quick QuoteOMCL - ) and Doximity ( DOCS Quick QuoteDOCS - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing market with new free offering.
Doximity ( DOCS ) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, Doximity (DOCS) closed at $59.7, marking a -2.13% move from the previous day.
UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs
UNH misses Q2 earnings estimates as surging medical costs slash EPS 40%, despite revenue growth and Optum Rx strength.
Universal Health Q2 Earnings Beat on Strong Acute Care Admissions
UHS tops Q2 estimates with EPS up 24% as strong acute care and behavioral admissions drive revenue growth.
ImmunoPrecise Antibodies Ltd. ( IPA ) Reports Q4 Loss, Lags Revenue Estimates
ImmunoPrecise Antibodies (IPA) delivered earnings and revenue surprises of -100.00% and -17.86%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Community Health Q2 Earnings Miss on Declining Patient Days
CYH posts Q2 loss despite revenue beat, as patient days and adjusted admissions decline year over year.
Molina Healthcare Q2 Earnings Miss on Rising Medical Care Costs
MOH's Q2 earnings lag estimates as rising medical care costs offset gains from premiums and rate hikes.
Doximity ( DOCS ) Upgraded to Strong Buy: Here's Why
Doximity (DOCS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Healthy Returns: Researchers move closer to a universal cancer vaccine
University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings season is approaching.
Doximity ( DOCS ) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Doximity (DOCS) stood at $59.38, denoting a -1.44% move from the preceding trading day.
Doximity ( DOCS ) Rises Higher Than Market: Key Facts
Doximity (DOCS) concluded the recent trading session at $61.55, signifying a +2.24% move from its prior day's close.
Do Options Traders Know Something About Doximity Stock We Don't?
Investors need to pay close attention to DOCS stock based on the movements in the options market lately.
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?
OPRX doubles down on AI and subscriptions, but margin mix and retention risks loom over its platform transformation.
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation - Doximity ( NYSE:DOCS )
SAN DIEGO, July 09, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. DOCS shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.
This Microsoft Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Bloom Energy ( NYSE:BE ) , Charles River ( NYSE:CRL )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock?
OPRX surged 69.3% in three months as rising contracted revenue and subscription gains boost confidence and guidance.
How Do Investors Really Feel About Doximity? - Doximity ( NYSE:DOCS )
Doximity's DOCS short percent of float has risen 13.82% since its last report. The company recently reported that it has 5.59 million shares sold short, which is 4.2% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.65 days to cover their ...
Doximity ( DOCS ) Laps the Stock Market: Here's Why
Doximity (DOCS) concluded the recent trading session at $61.09, signifying a +1.13% move from its prior day's close.
Does DOCS' Shift Toward Enterprise Offerings Signal a Long-Term Pivot?
DOCS sharpens its enterprise focus with AI and workflow tools, signaling a deeper pivot beyond pharma marketing roots.
Will AI Tools Like DocsGPT Drive the Next Leg of Growth for DOCS?
DOCS is leaning on AI tools like Doximity GPT to fuel growth after a strong FY25, but monetization remains early-stage.
DOCS vs. IRTC: Who Will Win High-Stakes AI Showdown in Digital Health?
DOCS and IRTC are redefining digital health with AI, but only one is winning big with investors in 2025's market surge.
OGN or DOCS: Which Is the Better Value Stock Right Now?
OGN vs. DOCS: Which Stock Is the Better Value Option?
HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth
Hims & Hers' 38.4% subscriber growth and $576.4 million online revenues highlight the power of its personalized subscription model.
What Does the Market Think About Doximity? - Doximity ( NYSE:DOCS )
Doximity's DOCS short percent of float has fallen 48.1% since its last report. The company recently reported that it has 4.90 million shares sold short, which is 3.69% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.19 days to cover their ...
DOCS Boosts Client Retention via Workflow Integration and AI Tools
Doximity strengthens client loyalty by embedding AI tools and clinical workflows into its platform for medical professionals.
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm - Doximity ( NYSE:DOCS )
NEW YORK, June 06, 2025 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. DOCS breached their fiduciary duties to shareholders.
Doximity Declines 4.4% in a Month: How to Play the Stock Now?
DOCS slips 4.4% in a month despite strong Q4 results, margin gains and raised guidance -- is there a buying opportunity?
Doximity Rides on Telehealth Demand: Will This Drive Sales Further?
DOCS posts strong Q4 revenue growth and record user engagement as demand for telehealth and AI tools hits new highs.
CrowdStrike, Asana And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Asana ( NYSE:ASAN ) , ATAI Life Sciences ( NASDAQ:ATAI )
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Wednesday. Shares of CrowdStrike Holdings, Inc. CRWD fell sharply in today's pre-market trading after the company reported first-quarter results.
SHAREHOLDER ALERT: Morris Kandinov Investigating DV, MANH, DOCS, and SEDG; Shareholders are Encouraged to Contact the Firm - DoubleVerify Holdings ( NYSE:DV ) , Doximity ( NYSE:DOCS )
SAN DIEGO, June 03, 2025 ( GLOBE NEWSWIRE ) -- National law firm Morris Kandinov is investigating DoubleVerify Holdings, Inc., Manhattan Associates, Inc., Doximity, Inc., and SolarEdge Technologies, Inc. If you are a current owner of shares, contact [email protected] or call ( 619 ) 780-3993.
Jim Cramer Praises Rivian, Recommends Pan American Silver - Lucid Group ( NASDAQ:LCID ) , Doximity ( NYSE:DOCS )
Jim Cramer says Pony AI is a "young person stock." Marvell is "right to be bought here," says Cramer. Get 5 'Hidden Gem' stock picks and daily rankings-now 60% off for Memorial Day. On CNBC's "Mad Money Lightning Round," Jim Cramer said Rivian Automotive, Inc. RIVN is better than Lucid Group, ...
